VKTX in the 13F filings
Viking Therapeutics Inc · CUSIP 92686J106
- Quarter end
- 30 Sep 2024
- the date the book describes
- Filed
- 5 Nov 2026
- latest of these filings; the earliest 12 Nov 2024
- Managers listing it
- 5
- at least, of 95 tracked, among listed positions
- Comparable managers
- 94
- filed both Q2 2024 and Q3 2024; 4 listed it in both
- Shares listed
- 17,799,734
- combined, among listed positions
- Reported value
- $1.1bn
- combined, at the quarter end
Among the 94 comparable managers: 2 buyers (opened or added shares) and 3 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing VKTX in Q3 2024
5 of 5 holders
| Action | Filing | |||||
|---|---|---|---|---|---|---|
| Fidelity (FMR LLC) | 16,619,430 | $1.1bn | 0.06% | Added | +79,149 | 5 Nov 2026 (the filing on sec.gov) |
| Viking Global Investors LP | 721,926 | $46m | 0.17% | Trimmed | -632,524 | 14 Nov 2024 (the filing on sec.gov) |
| ExodusPoint Capital Management LP | 263,159 | $17m | 0.10% | Added | n.a. | 12 Nov 2024 (the filing on sec.gov) |
| Discovery Capital Management LLC | 131,400 | $8.3m | 1.02% | Trimmed | -15,500 | 13 Nov 2024 (the filing on sec.gov) |
| Woodline Partners LP | 63,819 | $4.0m | under 0.1% | Trimmed | -1,607 | 14 Nov 2024 (the filing on sec.gov) |
Largest increases and reductions, by shares
Increases
- Fidelity (FMR LLC)existing position · 16,619,430 shares now+79,149
Reductions
- Viking Global Investors LPexisting position · 721,926 shares now-632,524
- Discovery Capital Management LLCexisting position · 131,400 shares now-15,500
- Woodline Partners LPexisting position · 63,819 shares now-1,607
New positions and exits
New (0)
No new position among listed positions.
Exited (0)
No exit shown by a manager’s own filing.
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2018 | 1 | $949k | n.a. | n.a. |
| Q3 2018 | 3 | $20m | n.a. | n.a. |
| Q4 2018 | 1 | $161k | n.a. | n.a. |
| Q1 2019 | 1 | $6.5m | n.a. | n.a. |
| Q2 2019 | 2 | $5.4m | n.a. | n.a. |
| Q3 2019 | 1 | $751k | n.a. | n.a. |
| Q4 2020 | 1 | $112k | n.a. | n.a. |
| Q1 2021 | 1 | $245k | n.a. | n.a. |
| Q2 2021 | 2 | $1.0m | n.a. | n.a. |
| Q3 2021 | 2 | $769k | n.a. | n.a. |
| Q4 2021 | 1 | $627k | n.a. | n.a. |
| Q1 2022 | 1 | $290k | n.a. | n.a. |
| Q2 2022 | 1 | $849k | n.a. | n.a. |
| Q3 2022 | 2 | $3.5m | n.a. | n.a. |
| Q4 2022 | 3 | $13m | n.a. | n.a. |
| Q1 2023 | 4 | $71m | n.a. | n.a. |
| Q2 2023 | 1 | $57m | n.a. | n.a. |
| Q3 2023 | 3 | $54m | n.a. | n.a. |
| Q4 2023 | 2 | $138m | 2 | 1 |
| Q1 2024 | 7 | $1.6bn | 5 | 2 |
| Q2 2024 | 5 | $961m | 5 | 1 |
| Q3 2024 | 5 | $1.1bn | 2 | 3 |
| Q4 2024 | 6 | $794m | 4 | 3 |
| Q1 2025 | 4 | $61m | 4 | 2 |
| Q2 2025 | 3 | $72m | 3 | 0 |
| Q3 2025 | 6 | $117m | 6 | 0 |
| Q4 2025 | 6 | $202m | 18 | 9 |
| Q1 2026 | 2 | $156m | 10 | 18 |
| Q2 2026 | 4 | $183m | 20 | 6 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
VKTX and LLY →VKTX and JNJ →VKTX and VRTX →Choose a stock to compare with VKTX →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own VKTX, latest filings →Back to the 13F Explorer →